ClinicalTrials.gov
public full text
Public Domain
Doravirine Dose Optimisation in Pregnancy
A randomised, open label, controlled PK standard of care vs doravirine plus 2 nucleoside reverse transcriptase inhibitors backbone in pregnant women initiating combination antiretroviral therapy in the second trimester of pregnancy.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Obesogenic Origins of Maternal and Child Metabolic Health Involving Dolutegravir#836980
- Pregnancy and Neonatal Outcomes Following Antenatal Exposure to Raltegravir: a Pooled Analysis From the European Pregnancy and Paediatric Infections Cohort Collaboration (EPPICC)#836961
- Sofosbuvir/Velpatasvir Treatment of Chronic Hepatitis C During Pregnancy#843719
- Expectant Moms Managing Attention-Deficit/ Hyperactivity Disorder#873941
- Aimovig Pregnancy Exposure Registry#918841
Record · ID 1183704
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive